2019\u5e741\u670818\u65e5<\/p>\n
³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
<\/p>\n
³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b ³Ô¹Ï±¬ÁÏ)\u306f\u3001³Ô¹Ï±¬ÁÏ\u304c\u30d5\u30a9\u30fc\u30c1\u30e5\u30f3\u8a8c\u304c\u9078\u3076\u300c\u6025\u6210\u9577\u4f01\u696d100\u793e<\/a><\/strong>\u300d\u306e\u30a8\u30f3\u30bf\u30fc\u30d7\u30e9\u30a4\u30ba\u30fb\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u4f01\u696d\u306e\u7b2c2\u4f4d\u306b\u9078\u51fa\u3055\u308c\u3001\u30c7\u30ed\u30a4\u30c8\u793e\u306b\u3088\u308b\u300c2018\u30c6\u30af\u30ce\u30ed\u30b8\u30fcFast 500™<\/a><\/strong>\u300d\u306e\u8abf\u67fb\u3067\u3082\u3001\u6025\u6210\u9577\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u4f01\u696d\u306e1\u3064\u306b\u9078\u3070\u308c\u305f\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001³Ô¹Ï±¬ÁÏ\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f\u3053\u3061\u3089<\/a><\/strong>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n <\/p>\n \u307e\u305f\u3001PM360\u8a8c\u3067\u3082\u3001³Ô¹Ï±¬ÁÏ\u306b\u3088\u308b\u88fd\u54c1\u306e\u7d99\u7d9a\u7684\u306a\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3068\u30ea\u30fc\u30c0\u30fc\u30b7\u30c3\u30d7\u304c\u8a55\u4fa1\u3055\u308c\u3001³Ô¹Ï±¬ÁÏ Nitro<\/a><\/strong>\u304c\u300c2018\u5e74\u3067\u6700\u3082\u9769\u65b0\u7684\u306a\u88fd\u54c1<\/a><\/strong>\u300d\u306e1\u3064\u306b\u9078\u3070\u308c\u307e\u3057\u305f\u3002\u3055\u3089\u306b\u3001Pharmaceutical Manufacturing\u8a8c\u3067\u3082\u3001\u9ad8\u54c1\u8cea\u306e\u88fd\u85ac\u3092\u5b9f\u73fe\u3059\u308b\u305f\u3081\u306e\u5f79\u5272\u5225\u30c8\u30ec\u30fc\u30cb\u30f3\u30b0\u306b\u767a\u5c55\u3092\u3082\u305f\u3089\u3057\u305f\u3001³Ô¹Ï±¬ÁÏ Vault Training<\/a><\/strong>\u304c\u300c\u88fd\u85ac\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30a2\u30ef\u30fc\u30c9<\/a><\/strong>\u300d\u3092\u53d7\u8cde\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n ³Ô¹Ï±¬ÁÏ\u306e\u5275\u7acb\u8005\u517cCEO\u3067\u3042\u308bPeter Gassner\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c\u3053\u3046\u3057\u3066\u8a55\u4fa1\u3057\u3066\u3044\u305f\u3060\u3051\u305f\u306e\u3082\u3001\u512a\u308c\u305f\u88fd\u54c1\u3092\u4f5c\u308b\u305f\u3081\u306b\u3072\u305f\u3080\u304d\u306b\u53d6\u308a\u7d44\u3093\u3067\u304d\u305f³Ô¹Ï±¬ÁÏ\u30c1\u30fc\u30e0\u306e\u304a\u304b\u3052\u3067\u3059\u3002\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u3068\u306e\u9593\u306b\u5f37\u56fa\u306a\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u304c\u7bc9\u304b\u308c\u3066\u3044\u308b\u3053\u3068\u3001\u305d\u3057\u3066\u304a\u5ba2\u69d8\u306e\u6210\u529f\u3092\u5f15\u304d\u7d9a\u304d\u652f\u63f4\u3055\u305b\u3066\u3044\u305f\u3060\u3051\u308b\u3053\u3068\u3092\u3001\u5f53\u793e\u306f\u5149\u6804\u306b\u601d\u3063\u3066\u304a\u308a\u307e\u3059\u3002\u300d<\/p>\n \u30d5\u30a9\u30fc\u30c1\u30e5\u30f3\u8a8c\u304c³Ô¹Ï±¬ÁÏ<\/strong>\u30922<\/strong>\u5e74\u9023\u7d9a\u3067\u6025\u6210\u9577\u4f01\u696d\u306b\u9078\u51fa<\/strong><\/p>\n \u30d5\u30a9\u30fc\u30c1\u30e5\u30f3\u8a8c\u306f\u3001³Ô¹Ï±¬ÁÏ\u3092\u300c\u6025\u6210\u9577\u4e2d\u306e\u30a8\u30f3\u30bf\u30fc\u30d7\u30e9\u30a4\u30ba\u30fb\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u4f01\u696d<\/a><\/strong>\u300d\u306e\u7b2c2\u4f4d\u3001\u300c\u6025\u6210\u9577\u4f01\u696d100\u793e\u300d\u306e\u7dcf\u5408\u7b2c18\u4f4d\u306b\u9078\u51fa\u3057\u307e\u3057\u305f\u3002\u6bce\u5e74\u767a\u8868\u3055\u308c\u308b\u3053\u306e\u30ea\u30b9\u30c8\u3067\u306f\u3001\u904e\u53bb3\u5e74\u306b\u308f\u305f\u308b\u53ce\u76ca\u3001\u5229\u76ca\u3001\u682a\u5f0f\u306e\u30ea\u30bf\u30fc\u30f3\u306b\u304a\u3044\u3066\u3001\u30c8\u30c3\u30d7\u30af\u30e9\u30b9\u306e\u696d\u7e3e\u3092\u9054\u6210\u3057\u3066\u3044\u308b\u4f01\u696d\u3092\u30e9\u30f3\u30af\u4ed8\u3051\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n \u30c7\u30ed\u30a4\u30c8\u793e\u304c³Ô¹Ï±¬ÁÏ<\/strong>\u3092\u300c2018<\/strong>\u5e74\u30c6\u30af\u30ce\u30ed\u30b8\u30fcFast 500™<\/strong>\u300d\u306b\u9078\u51fa<\/strong><\/p>\n \u30c7\u30ed\u30a4\u30c8\u793e\u306f³Ô¹Ï±¬ÁÏ\u3092\u3001\u5317\u7c73\u306e\u6025\u6210\u9577\u4e2d\u306e\u4e0a\u5834\u30fb\u975e\u4e0a\u5834\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u306e1\u793e\u3068\u3057\u3066\u8a55\u4fa1\u3057\u307e\u3057\u305f\u3002³Ô¹Ï±¬ÁÏ\u306f\u30c7\u30ed\u30a4\u30c8\u793e\u306e\u300c\u30c6\u30af\u30ce\u30ed\u30b8\u30fcFast 500™\u300d\u306b5\u5e74\u9023\u7d9a\u3067\u9078\u51fa\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n \u30c7\u30ed\u30a4\u30c8\u793e\u306e\u526f\u4f1a\u9577\u3067\u3042\u308a\u3001\u7c73\u56fd\u306e\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3001\u30e1\u30c7\u30a3\u30a2\u3001\u901a\u4fe1\u95a2\u4fc2\u306e\u30ea\u30fc\u30c0\u30fc\u3067\u3082\u3042\u308bSandra Shirai\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c\u30a4\u30ce\u30d9\u30fc\u30bf\u30fc\u3067\u3042\u308b\u3053\u308c\u3089\u306e\u4f01\u696d\u306f\u3001\u7834\u58ca\u7684\u306a\u30a2\u30a4\u30c7\u30a2\u3092\u88fd\u54c1\u3001\u30b5\u30fc\u30d3\u30b9\u3001\u30e6\u30fc\u30b6\u30fc\u30a8\u30af\u30b9\u30da\u30ea\u30a8\u30f3\u30b9\u3068\u3057\u3066\u5177\u73fe\u5316\u3057\u3001\u65b0\u898f\u9867\u5ba2\u3092\u5f15\u304d\u4ed8\u3051\u3066\u3001\u76ee\u899a\u307e\u3057\u3044\u6210\u9577\u3092\u9042\u3052\u3066\u3044\u307e\u3059\u3002\u300d<\/p>\n PM360<\/strong>\u8a8c\u304c³Ô¹Ï±¬ÁÏ Nitro<\/strong>\u3092\u300c2018<\/strong>\u5e74\u3067\u6700\u3082\u9769\u65b0\u7684\u306a\u88fd\u54c1\u300d\u3068\u3057\u3066\u9078\u51fa<\/strong><\/p>\n PM360\u8a8c\u306f\u3001\u5e74\u9593\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u7279\u96c6\u53f7\u306b\u304a\u3044\u3066\u3001³Ô¹Ï±¬ÁÏ Nitro\u3092\u300c2018\u5e74\u3067\u6700\u3082\u9769\u65b0\u7684\u306a\u88fd\u54c1\u300d\u3068\u3057\u3066\u8a55\u4fa1\u3057\u307e\u3057\u305f\u3002\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306b\u7279\u5316\u3057\u305f\u3001\u5206\u6790\u3068AI\u5bfe\u5fdc\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3092\u5099\u3048\u305f³Ô¹Ï±¬ÁÏ Nitro\u306f\u3001\u30ab\u30b9\u30bf\u30e0\u30c7\u30fc\u30bf\u30a6\u30a7\u30a2\u30cf\u30a6\u30b9\u306e\u958b\u767a\u3084\u4fdd\u5b88\u306b\u304b\u304b\u308b\u6642\u9593\u3068\u52b4\u529b\u3092\u524a\u6e1b\u3057\u307e\u3059\u3002<\/p>\n PM360\u306eCEO\u517c\u767a\u884c\u8005\u3067\u3042\u308bAnna Stashower\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c\u3053\u306e\u9078\u51fa\u30ea\u30b9\u30c8\u306f\u3001\u696d\u754c\u306b\u304a\u3044\u3066\u72ec\u5275\u7684\u306a\u5f71\u97ff\u529b\u3092\u767a\u63ee\u3057\u3066\u3044\u308b\u3068PM360\u304c\u8003\u3048\u308b\u4f01\u696d\u3001\u88fd\u54c1\u3001\u6226\u7565\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002\u696d\u754c\u95a2\u4fc2\u8005\u304c\u3053\u308c\u3089\u306e\u30a4\u30ce\u30d9\u30fc\u30bf\u30fc\u3068\u5354\u529b\u3057\u3066\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u6d3b\u7528\u3057\u3001\u60a3\u8005\u3084\u533b\u5e2b\u3001\u533b\u7642\u696d\u754c\u306e\u305d\u306e\u4ed6\u306e\u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc\u306b\u3088\u308a\u826f\u3044\u3082\u306e\u3092\u63d0\u4f9b\u3059\u308b\u3053\u3068\u3092\u671f\u5f85\u3057\u3066\u3044\u307e\u3059\u3002\u300d<\/p>\n Pharmaceutical Manufacturing<\/strong>\u8a8c\u304c³Ô¹Ï±¬ÁÏ<\/strong>\u306e\u88fd\u54c1\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u8a55\u4fa1<\/strong><\/p>\n \u300c\u88fd\u85ac\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30a2\u30ef\u30fc\u30c9\u300d\u306f\u3001\u696d\u754c\u306e\u30ea\u30fc\u30c0\u30fc\u3068\u3057\u3066\u8a8d\u3081\u3089\u308c\u305f\u4f01\u696d\u306e\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3084\u30b7\u30b9\u30c6\u30e0\u306b\u4e0e\u3048\u3089\u308c\u307e\u3059\u3002Pharmaceutical Manufacturing\u8a8c\u3067\u306f\u3001³Ô¹Ï±¬ÁÏ Vault Training\u304c\u7d44\u7e54\u5168\u4f53\u306b\u308f\u305f\u308b\u30c8\u30ec\u30fc\u30cb\u30f3\u30b0\u3092\u4e00\u5143\u7684\u306b\u8868\u793a\u3067\u304d\u308b\u3053\u3068\u304c\u8a55\u4fa1\u3055\u308c\u307e\u3057\u305f\u3002<\/p>\n Pharmaceutical Manufacturing\u8a8c\u306e\u30c1\u30fc\u30d5\u30b3\u30f3\u30c6\u30f3\u30c4\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3067\u3042\u308bKaren Langhauser\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c³Ô¹Ï±¬ÁÏ\u306e\u30c8\u30ec\u30fc\u30cb\u30f3\u30b0\u30b7\u30b9\u30c6\u30e0\u306f\u3001\u6570\u30f5\u6708\u304b\u304b\u308b\u8a8d\u5b9a\u307e\u3067\u306e\u6642\u9593\u3092\u6570\u65e5\u306b\u307e\u3067\u77ed\u7e2e\u3059\u308b\u53ef\u80fd\u6027\u3092\u79d8\u3081\u3066\u3044\u307e\u3059\u3002\u88fd\u85ac\u6a5f\u5668\u306e\u30b5\u30d7\u30e9\u30a4\u30e4\u30fc\u306f\u81ea\u793e\u88fd\u54c1\u306b\u591a\u5927\u306a\u6642\u9593\u3092\u8cbb\u3084\u3057\u3066\u3044\u308b\u305f\u3081\u3001\u3053\u306e\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u306f\u8a55\u4fa1\u3055\u308c\u308b\u3079\u304d\u3082\u306e\u3067\u3042\u308b\u3068\u611f\u3058\u3066\u3044\u307e\u3059\u3002\u300d<\/p>\n <\/p>\n \u3010³Ô¹Ï±¬ÁÏ Systems\u793e\u306b\u3064\u3044\u3066\u3011 \u3010Forward-looking Statements\u3011<\/strong> 2019\u5e741\u670818\u65e5 ³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e ³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751…<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322,341],"tags":[],"class_list":["post-42314","post","type-post","status-publish","format-standard","hentry","category-press-release","category-case-study","blog-product-content-management","blog-product-data"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42314"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=42314"}],"version-history":[{"count":7,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42314\/revisions"}],"predecessor-version":[{"id":42325,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42314\/revisions\/42325"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=42314"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=42314"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=42314"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n<\/strong>³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u3084\u305d\u306e\u4ed6\u306e\u898f\u5236\u3092\u53d7\u3051\u308b\u88fd\u9020\u696d\u8005\u5411\u3051\u306b\u3001\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067675\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u3092\u64c1\u3057\u3001\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-Q for the period ended October 31, 2018. This is available on the company\u2019s website at www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"